Scenic Biotech

Midlum, Friesland, The Netherlands

http://www.scenicbiotech.com/

Company profile

Scenic Biotech company profile

Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors as a new class of drug targets.The company's immunotherapy technologies tackle diseases on the genetic level and focuses on disease suppressing genes., it uses genomics to develop innovative therapies for patients affected by severe diseases.

Business identity

Website: http://www.scenicbiotech.com/
Contact email: [email protected]
Operating status: Active
Company type: For Profit
Employee range: 11-50 employees
Revenue range: $1M-$10M
Founded: 2017-01-01, Year

Headquarters

Headquarters: Midlum, Friesland, The Netherlands
Country code: NL
Continent: Europe

Capital profile

Funding and company signals

Funding stage: Early Stage Venture
Funding rounds: 3
Total equity funding: $38.3M
Last funding: Series A / $31M / 2022-03-09
Last equity funding: Series A / $31M
Investors: 8
Lead investors: 6
Founders: 2
Articles: 37

Categories and groups

Biometrics Biotechnology Collaborative Consumption Life Science Biotechnology Data and Analytics Other Science and Engineering

Founders and investors

Founders

Sebastian NijmanThijn Brummelkamp

Lead investors

BioGeneration VenturesBioMedPartnersEIR VenturesInkefNetherlands Enterprise AgencyVesalius Biocapital Partners

Investors

BioGeneration VenturesBioMedPartnersInkefOxford Science EnterprisesVesalius Biocapital Partners